Treating hispanic patients for type 2 diabetes mellitus: Special considerations

Journal of the American Osteopathic Association

Volumn 108, Issue 5 SUPPL 3, 2008, Pages

  Freeman, Jeffrey S ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; GLIMEPIRIDE; GLITAZONE DERIVATIVE; HYDROCHLOROTHIAZIDE; INSULIN; IRBESARTAN; METFORMIN; NICOTINIC ACID; PIOGLITAZONE; SIMVASTATIN; SITAGLIPTIN; VILDAGLIPTIN;

ADULT; ALBUMINURIA; BLOOD PRESSURE; CASE REPORT; CREATININE CLEARANCE; DEPRESSION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET; DRUG DOSE TITRATION; DRUG SUBSTITUTION; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HISPANIC; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MICROANEURYSM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PERIPHERAL VASCULAR DISEASE; PROTEIN RESTRICTION; REVIEW; UNITED STATES; WALKING;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; UNITED STATES;

EID: 44849136879     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. United States Census 2000. US Census Bureau Web site. Available at: http://www.census. gov/main/www/cen2000.html. Accessed March 27, 2008.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Atlanta, Ga: US Department of Human Services, Centers for Disease Control and Prevention; 2003. Available at: http://www.cdc.gov/diabetes/pubs/factsheet. htm. Accessed March 27, 2008.
3. Hogan P, Dall T, Nikolov P; for the American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932. Available at: http://care.diabetesjournals. org/cgi/content/full/26/3/917. Accessed March 27, 2008.
4. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524. Available at: http:// care.diabetesjournals.org/cgi/reprint/21/4/518. Accessed March 27, 2008.
5. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167. Available at: http://diabetes.diabetesjournals.org/cgi/content/ full/52/8/2160. Accessed March 27, 2008.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
7. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. Available at: http://jama.ama-assn.org/cgi/content/full/285/ 19/2486. Accessed March 27, 2008.
8. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [published correction appears in Diabetes Care. 2006;49:2816-2818] Diabetes Care. 2006;29:1963-1972. Available at: http://care. diabetesjournals.org/cgi/content/full/29/ 8/1963. Accessed March 21, 2008.
9. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care. 2008;31(suppl 1):S12-S54. Available at: http://care.diabetesjournals.org/cgi/content/full/31/ Supplement_1/S12. Accessed March 27, 2008.
10. Lebovitz HE. Insulin secretagogues: old and new. Diabetes Rev. 1999;7:139-153.
11. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22:403-408. Available at: http://care. diabetesjournals.org/cgi/reprint/22/3/403. Accessed March 27, 2008.
12. American Osteopathic Association, American College of Osteopathic Internists, American College of Osteopathic Family Physicians, American Academy of Physician Assistants, The Diabetes Consortium Inc. Addressing overweight and obesity: evolving to a medical consensus [consensus report]. J Am Osteopath Assoc. 2008;108(suppl 1):S2-S15. Available at: http://www.jaoa.org/cgi/ reprint/ 108/2_suppl_1/S2. Accessed March 29, 2008.
13. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. Glycemic durability of rosiglitazone, metformin, or glyburide mono - therapy [published correction appears in N Engl J Med. 2007;356:1387-1388]. N Engl J Med. 2006;355:2427-2443. Epub December 4, 2006.
14. Mayer-Davis EJ, D'Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, et al. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998;279:669-674.
15. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care. 1997;20:322-329.
16. Caballero AE. Diabetes in minority populations. In: Joslin's Diabetes Mellitus. 14th ed. New York NY: Lippincott Williams & Wilkins; 2005:505-524.
17. Pandey DK, Labarthe DR, Goff DC, Chan W, Nichaman MZ. Community-wide coronary heart disease mortality in Mexican Americans equals or exceeds that in non-Hispanic whites: the Corpus Christi Heart Project. Am J Med. 2001;110:81-87.
18. Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarthe DR, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes. 1994;43:897-902.
19. Xiang AH, Peters RK, Kjos SL, Ochoa C, Marroquin A, Goico J, et al. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1986-1991. Epub December 28, 2004. Available at: http://jcem.endojournals.org/cgi/content/full/90/4/1986. Accessed April 27, 2008.
20. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators [published correction appears in Lancet. 2000;356:860]. Lancet. 2000;355:253-259.
21. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, et al; for the Collaborative Study Group. Reno-protective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-860.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
23. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003;26:2119-2125. Available at: http://care.diabetesjournals.org/cgi/content/full/26/7/2119. Accessed March 28, 2008.
24. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, et al. Lipoprotein management in patients with cardiometabolic risk. 2008;31:811-822. Available in: http://care. diabetesjournals.org/cgi/reprint/31/ 4/811. Accessed April 27, 2008.
25. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7-22.
26. Fish and omega-3 fatty acids - AHA recommendation. American Heart Association Web site. Available at: http://www.americanheart.org/presenter. jhtml?identifier=4632. Accessed March 28, 2008.
27. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [published correction appears in Diabetes Care. 1997;20:1048]. Diabetes Care. 1997;20:614-620.
28. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005;28:1339-1345. Available at: http://care.diabetesjournals.org/cgi/ content/full/28/6/1339. Accessed March 28, 2008.
29. Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P; for the Sitagliptin Study 019 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006;28:1556-1568.
30. Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care. 2007;30:890-895. Epub February 2, 2007. Available at: http://care.diabetesjournals.org/cgi/ content/full/30/4/890. Accessed March 28, 2008.
31. Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P; for the Sitagliptin Study 035 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes Obes Metab. 2007;9:733-745. Epub June 26, 2007.
32. Browning JD, Kumar KS, Saboorian MH, Thiele DL. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol. 2004;99:292-298.
33. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemic. Chest. 2008;133:496-506.